openPR Logo
Press release

4th International Conference on Hypertension & Healthcare

01-30-2018 12:39 PM CET | Health & Medicine

Press release from: Conference Series Ltd

4th International Conference on Hypertension & Healthcare

We take the privilege of hosting International Hypertension meetings worldwide and very excited to expand to 4th International Conference on Hypertension & Healthcare to be held in beautiful city Zurich, Switzerland in the month of September 10th- 11th, 2018. As with the three meetings, the Hypertension 2018 will be on high-level updates, debates, hot topics and future research directions in the areas of Cardiology, cardiovascular diseases, Pulmonary Hypertension, Hypertension & Stroke, Advanced Treatment Approaches and many more.

This format has proven to be extremely popular with Clinicians and researchers, Heads, Deans and Professors of Hypertension or Cardiology departments. I do hope you will mark this date in your calendar, check the website for updates and join us in Zurich for what promises to be another exciting, cutting edge exploration of the latest advances in hypertension and cardiovascular diseases.

Theme of the conference: Control Hypertension: Add life to Longevity

For more details of the conference please have a glance at our website: https://hypertension.conferenceseries.com/

Conference Highlights
Hypertension
High Blood Pressure and Kidney Diseases
Pulmonary Hypertension
Gestational Hypertension
Hypertension & Stroke
Hypertension and Diabetes
Hypertensive Heart Disease
Evaluation of Hypertension
Causative Factors, Risk Assessment and Complications
Diagnosis and Pathophysiology of Hypertension
Anti- Hypertensive Medications
Hypertension Therapy Devices
Diet and lifestyle in Hypertension Management
Nursing Management of Hypertension
Advanced Treatment Approaches
Clinical Trials and Case Reports

For Abstract submission please visit the link :https://hypertension.conferenceseries.com/abstract-submission.php

We look forward to welcoming you to Zurich!

Conference Series LLC through its Open Access Initiative is committed to create real and reliable contributions to the scientific community. Conference Series Ltd organize 600+ Conferences once a year across USA, Europe & Asia with support from a thousand additional scientific societies and Publishes 400+ Open access journals that contains over 30000 eminent personalities, putative scientists as editorial board members.

Jessie Alison
Program Director
Hypertension 2018
Kemp House, 152 City Road, London EC1V 2NX
Email: hypertension@cardiologyconference.org
Phone No: +44-8000148923

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release 4th International Conference on Hypertension & Healthcare here

News-ID: 922502 • Views:

More Releases for Hypertension

Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027. Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion. Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC
Ocular Hypertension - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Ocular Hypertension - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ocular Hypertension - Pipeline Review, H2 2017, provides an overview of the Ocular Hypertension (Ophthalmology) pipeline landscape. Ocular hypertension occurs when the pressure inside the eye (intraocular pressure) is higher than normal. If the aqueous humor
Hypertension: Often unnoticed, always a risk
Vital mushrooms provide a valuable contribution in the prevention and therapy of hypertension Hypertension is considered one of the greatest health problems of the modern age. In the United Kingdom alone, according to data from the NHS, about 12,5 million people - almost every fourth - are affected. The great danger: Although hypertension can cause further serious diseases, many sufferers do not suspect their hypertension. They feel well and have
Ocular Hypertension-Pipeline Review H2 2017
ReportsWeb.com has announced the addition of the “Ocular Hypertension-Pipeline Review H2 2017” this report provides an overview of the Ocular Hypertension (Ophthalmology) pipeline landscape. Ocular hypertension occurs when the pressure inside the eye (intraocular pressure) is higher than normal. If the aqueous humor does not flow through the trabecular meshwork properly, fluid pressure in the eye builds up, causing ocular hypertension. There are no symptoms with ocular hypertension. Risk factors include
Ocular Hypertension - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Ocular Hypertension - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ocular Hypertension - Pipeline Review, H1 2017, provides an overview of the Ocular Hypertension (Ophthalmology) pipeline landscape. Ocular hypertension occurs when the pressure inside the eye (intraocular pressure) is higher than normal. If the aqueous
Renal Hypertension: Diagnosis & Treatment
“Hypertension & Cardiovascular disease after Kidney Transplantation” is one of the workshops to be conducted by Dr. Hossein Tabriziani of Loma Linda University, USA under the session ‘Renal Hypertension’ at the meeting 2nd International Conference on Hypertension & Healthcare which is going to be held at Amsterdam, Netherlands during September 11-13, 2017. High blood pressure is a leading cause of kidney disease and kidney failure ESRD (end stage renal disease). Hypertension